Manpreet Rehal
Optometrist · Reno, NVNPI 1295101244
Payments from drug & device makers
Across 28 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oyster Point Pharma, Inc.$166
- Tarsus Pharmaceuticals, Inc.$130
- Biotissue Holdings Inc.$67
- Bausch & Lomb Americas Inc.$58
- Harrow Eye, LLC$49
- Sun Pharmaceutical Industries Inc.$36
- plus $51 from 3 others
What the payments were for
- Food & beverage$557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oyster Point Pharma, Inc. | 10 | $166 |
| Tarsus Pharmaceuticals, Inc. | 6 | $130 |
| Biotissue Holdings Inc. | 3 | $67 |
| Bausch & Lomb Americas Inc. | 3 | $58 |
| Harrow Eye, LLC | 2 | $49 |
| Sun Pharmaceutical Industries Inc. | 1 | $36 |
| Johnson & Johnson Vision Care, Inc. | 1 | $27 |
| Coopervision Inc. | 1 | $15 |
| ABB Con-cise Optical Group LLC | 1 | $10 |
How this compares
$557 in reported general payments places this provider in the 40th percentile of 494 optometrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Loteprednol Etabonate | 11 | $1,215 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Reno
- Richard BorenReno$27K
- Troy OgdenReno$7K
- Tonya HubbardReno$6K
- Annabelle CardonaReno$5K
- Christina DanleyReno$5K
- Douglas DevriesSparks$1.3M
- Adam SchwartzLas Vegas$339K
- Amel YoussefLas Vegas$245K
- Stella LauNorth Las Vegas$100K
- Eric BrookerLas Vegas$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.